Celltrion | 068270 - Fremdkapital





Fremdkapital Veränderung Datum
Akebia Therapeutics USD 12.78M 11.98M 2026-09
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 412.88B 1.61B 2026-06
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
IQVIA Holdings USD 14.82B 1.12B 2026-09
Moderna USD 3.55B 2.95B 2026-09
Organon & Co USD 8.49B 6M 2026-09
Revvity USD 2.63B 968K 2026-09
Tectonic Therapeutic USD 17K 26K 2026-03
Viatris USD 11.59B 24.9M 2026-09
Xeris Pharmaceuticals USD 189.71M 906K 2026-09